health

The relentless grip of COVID-19, a pandemic that has claimed over 7 million lives globally, has left a lasting scar across the world. From crowded hospitals to empty streets, its impact is felt incessantly. According to recent statistics, this virus has etched its position as the second-deadliest disease, only shadowed

In a controversial move that has sent shockwaves through the scientific community, the Trump administration has once again slashed funding for health research among federal agencies. While political pundits and healthcare experts dissect the implications of these cuts, CBS News medical contributor Dr. Céline Gounder sheds light on what these

A New Dawn in COVID-19 Immunology In an era where understanding immunity against SARS-CoV-2 is paramount, a pioneering study reveals a groundbreaking method to analyze these vital antibodies – flow cytometric assay. Scientists from the National Center for Toxicological Research have introduced a novel approach for detecting both IgG and IgM

A Landmark Moment in Vascular Surgery at UC Davis Health In an unprecedented advancement in the field of vascular surgery, UC Davis Health has successfully implemented a groundbreaking medical device, signifying a monumental leap forward in the treatment of thoracic aortic diseases. The Zenith Alpha® 2 Thoracic Endovascular Graft offers

A Rising Risk: Hypertension and COVID-19 Hypertension is a significant preexisting condition among hospitalized COVID-19 patients. As chronic high blood pressure interacts with SARS-CoV-2, it may predispose patients to severe clinical outcomes. The connection between these illnesses lies within the bustling networks of biological pathways and molecular interactions, especially unexplored

In an era where media holds the power to shape public perception, the role it plays in farm safety cannot be underestimated. As stated in Public Health Institute, the recent study from PHI’s Berkeley Media Studies Group has shed light on this critical intersection, revealing profound insights and opportunities

In a significant leap forward for combating the deadly Middle East Respiratory Syndrome (MERS) coronavirus, the Coalition for Epidemic Preparedness Innovations (CEPI) has announced a $2.6 million investment to propel Uvax Bio’s groundbreaking MERS vaccine candidate into preclinical trials. As one of the most lethal coronaviruses, MERS poses